CBCornelius Jakob van Beekum

Cornelius Jakob van Beekum

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cornelius Jakob van Beekum has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multicentre assessment of interactive 3D holograms for enhanced preoperative planning for colorectal liver metastasis resection

    by Philipp Kron, Mikolaj R. Kowal, Mohammed Ibrahim, Silvio Nadalin, Andre Mihaljevic, Johann Spatz, Alexander Gratz, Bernhard W. Renz, Christian Heiliger, Florian Bösch, et al.

  • Crossover kidney donation: A potential analysis from the Hannover Transplant Center

    by Cornelius Van Beekum, Irina Scheffner, Philipp Felgendreff, Markus Quante, Nicolas Richter, Rainer Blasczyk, Nele Kanzelmeyer, Dieter Haffner, Kai M. Schmidt-Ott, Moritz Schmelzle, et al.

    Potenzialanalyse am Transplantationszentrum Hannover

  • Open Access

    Early Morbidity and Survival After Left Lateral Segment Versus Whole Liver Graft Transplantation in Children

    by Helena Linge, Eva‐Doreen Pfister, Vanessa Muth, Sahar Arbabzadah, Jan Forner, Teresa Linge, Nicolas Richter, Markus Quante, Tung‐Yu Tsui, Ulrich Baumann, et al.

    Background: Left lateral segment (LLS) grafts expand graft availability for infants and small children requiring liver transplantation (LT). However, their cumulative early postoperative burden compared with whole liver grafts (WLGs) remains incompletely characterized. Methods: This retrospective single‐center cohort study included 95 consecutive primary pediatric LT recipients treated between 2019 and 2024, comprising 56 LLS and 39 WLG recipients. Cumulative postoperative morbidity within 90 days was quantified using the Comprehensive Complication Index (CCI). Additional outcomes included biliary and vascular complications, unplanned surgical reinterventions, length of stay, graft loss, retransplantation, and graft and patient survival. Results: LLS recipients were younger and smaller than WLG recipients. Cumulative 90‐day morbidity was greater after LLS transplantation (median CCI 53 vs. 45, p = 0.002). LLS recipients had higher rates of bile leakage (18% vs. 3%, p = 0.024), intra‐abdominal bleeding (15% vs. 0%, p = 0.019), and unplanned surgical reintervention (43% vs. 8%, p < 0.001). Although the overall incidence of biliary complications was similar between groups, anastomotic biliary strictures during follow‐up were more frequent after WLG transplantation (28% vs. 9%, p = 0.014). Hospital stay was longer after LLS transplantation (median 43 vs. 27 days, p < 0.001). No statistically significant differences in graft loss, retransplantation, or graft and patient survival were detected between groups. Conclusions: LLS transplantation was associated with greater cumulative morbidity within 90 days, characterized by higher rates of bile leakage, intra‐abdominal bleeding, unplanned surgical reintervention, and prolonged hospitalization. Despite this greater early postoperative burden, no statistically significant differences in graft loss, retransplantation, or graft and patient survival were detected during the available follow‐up. These findings support continued use of LLS grafts to expand transplant access. Given the associated early morbidity, it highlights the importance of an experienced surgical and medical team.

  • Biliary complications in pediatric living donor liver transplantation: An international multicenter analysis of risk and prognostic factors

    by Kaihang Wang, Omid Madadi-Sanjani, Yuan Liu, Dimitri A. Raptis, Vasanthakumar Gunasekaran, Ashwin Rammohan, Seisuke Sakamoto, Hajime Uchida, Piotr Kaliciński, Nicolas Goldaracena, et al.

    Biliary reconstruction is often considered the Achilles’ heel of liver transplantation, yet risk factors and outcomes remain poorly defined, particularly in pediatric living donor liver transplantation (LDLT). This international multicenter study aims to identify predictors of biliary complications and evaluate their impact on long-term outcomes. The study included 2665 pediatric patients who underwent LDLT between January 2019 and December 2023 across 19 centers. Multivariable logistic regression was performed to identify risk factors, while time-dependent Cox models were used to assess the impact on survival. The median recipient age was 11 months (IQR: 6.3–34.6), and biliary atresia was the most common diagnosis (59.7%). Bile leak and anastomotic stricture occurred in 3.6% (n=97) and 1.9% (n=51) of patients, respectively. For bile leak, higher donor BMI was an independent predictor (OR 1.09 per kg/m 2 , 95% CI: 1.02–1.17). For anastomotic strictures, longer cold ischemia time was a significant predictor (OR 1.36 per hour, 95% CI: 1.03–1.79). Bile leak (aHR 4.39, 95% CI: 1.04–18.60) and biliary stricture (aHR 6.26, 95% CI: 1.58–24.80) were associated with worse graft survival. Patient survival was not significantly impacted by bile leak and stricture. Early complications more often required surgery, but survival and failure-to-rescue rates were similar regardless of treatment approach. Ultimately, bile leak and anastomotic stricture remain significant threats to graft survival. The identified risk factors offer insights for risk stratification and prevention strategies aimed at improving outcomes in children undergoing LDLT.

  • Open Access

    Left Lateral Segment Liver Transplantation in Small Infants: Outcomes From a High‐Volume Center

    by Helena Linge, Eva‐Doreen Pfister, Vanessa Muth, Sahar Arbabzadah, Jan Forner, Lisa Felgendreff, Nicolas Richter, Markus Quante, Moritz Schmelzle, Ulrich Baumann, et al.

    Background: Graft selection in small infants is challenging due to size mismatch and the associated risk of vascular or biliary complications. Methods: In this retrospective single‐center study, 57 pediatric liver transplants using left lateral segment grafts performed between 2019 and 2024 were analyzed and compared by recipient weight (< 10 kg vs. ≥ 10 kg). Results: Overall graft survival was 88% in the < 10 kg group and 96% in the ≥ 10 kg group. Patient survival at 1, 2, and 4 years was similar between groups ( p = 0.500). The graft‐to‐recipient weight ratio was significantly higher in smaller recipients (4.64% vs. 2.37%, p < 0.05), and hepatic artery thrombosis occurred only in this group (9%). Biliary complications were comparable between cohorts (27% vs. 30%). Acute cellular rejection (57% vs. 12%, p < 0.001) and 90‐day readmissions (57% vs. 27%, p = 0.022) were significantly more common in children weighing ≥ 10 kg. Conclusion: In this selected cohort, left lateral segment transplantation was associated with excellent outcomes across weight groups. Acceptable results in small infants were achieved despite higher GRWR in a specialized setting, supporting LLS grafts as an important option to improve access to timely pediatric transplantation.

  • Open Access

    Two-Stage Hepatectomy for Cholangiocarcinoma Under Total Vascular Exclusion with Veno-venous ECMO Bypass and Controlled Closed-loop In Situ Hypothermic Oxygenated Perfusion of the Liver: The Hannover CLIP-Concept

    by Cornelius J. van Beekum, Philipp Felgendreff, Simon Störzer, Nora Nevermann, Hendrik Eismann, Christian Kühn, Thomas Wirth, Anna Saborowski, Björn Hartleben, Judith Pantke, et al.

    Background: Total vascular exclusion (TVE) enables the resection of centrally located liver tumors but remains associated with considerable intra- and perioperative morbidity. We present the Hannover Modification of TVE, which combines veno-venous extracorporeal membrane oxygenation (vvECMO) and a closed-loop in situ hypothermic oxygenated perfusion (CLIP) of the liver using the Bridge-to-Life ® VitaSmart system for targeted parenchymal protection. Methods: A 62-year-old woman with FGFR2-fused intrahepatic cholangiocarcinoma (iCCA) involving the hepatocaval confluence and all three hepatic veins, previously deemed unresectable, underwent partial ALPPS-preserving segment IVb. One week later, extended right trisectionectomy with reconstruction of the left hepatic vein was performed under TVE. Dual perfusion circuits were established: (1) a portocaval anastomosis was established and systemic and portal venous return was maintained via vvECMO; (2) cold (4 °C), oxygenated HTK solution was infused via a left portal vein catheter, drained through the hepatic veins into the IVC, and recirculated through a caval outflow cannula. Results: The CLIP approach ensured continuous oxygenation and hypothermia of the liver during resection and venous reconstruction without systemic cooling. Operative time was 4 hours and 3 minutes, with 72 minutes of CLIP and 130 minutes of vvECMO. Histopathology revealed a 6.5-cm iCCA (ypT1a, G2) with negative margins (R0). The postoperative course was uneventful, and the patient was discharged on postoperative day 7 with excellent liver function. Conclusions: The Hannover CLIP technique effectively combines controlled, recirculated HOPE with vvECMO. This approach minimizes ischemic injury to the liver, kidneys, and intestines and facilitates safe resection of highly complex central liver tumors under TVE.


  • Stellenwert der Robotik in der Leber- und Nierenlebendspende – Überblick über die aktuelle Studienlage und Ergebnisse einer Umfrage unter den deutschen Transplantationszentren

    by Cornelius J. van Beekum, Ulrich Zwirner, Dennis Kleine-Döpke, Gerrit Grannas, Jessica Singh, Nicolas Richter, Moritz Schmelzle, Philipp Felgendreff, Markus Quante

    Zusammenfassung: Die Vorteile minimalinvasiver Operationstechniken sind unbestritten. Mit der Einführung robotischer Assistenzsysteme wurde die klassische Laparoskopie weiterentwickelt und wird nun auch in der bisher von offenen Operationsverfahren geprägten Transplantationschirurgie eingesetzt, insbesondere bei Lebendspende-Operationen von Leber und Niere. Um den aktuellen Stand der Implementierung von robotischen Assistenzsystemen in der Transplantationschirurgie zu untersuchen, wurden die Ergebnisse internationaler Studien auf diesem Gebiet zusammengefasst und mit einer nationalen Befragungsstudie zum Einsatz der robotischen Lebendspende korreliert.Es erfolgte zunächst eine narrative Zusammenfassung der MEDLINE-gelisteten Publikationen zum Thema robotische Nieren- und Leberlebendspende. Zusätzlich erfolgte eine Onlineumfrage unter den deutschen Lebendspendezentren mit 10 Fragen zum Einsatz der Robotik in der deutschen Transplantationschirurgie.International berichten insbesondere retrospektive Kohortenstudien aus wenigen Transplantationszentren von Vorteilen durch die Robotik, z. B. hinsichtlich Blutverlust, Patientenkomfort und Dauer des Krankenhausaufenthaltes. Bereits ein Drittel der deutschen Transplantationszentren führt Nierenlebendspende-Operationen robotisch assistiert durch, ein Fünftel der Zentren benutzt diese Technik nahezu ausschließlich (> 90% der Nierenlebendspenden). Ein anderes Bild ergibt sich bei der Leberlebendspende, wo nur eines der befragten Zentren begonnen hat, die linkslaterale Donorhepatektomie robotisch assistiert durchzuführen.Im Kontext der Lebendspende betonen Befürworter der Robotik technische Vorteile, höheren Patientenkomfort und eine steilere Lernkurve. Ein fortbestehender erheblicher Kritikpunkt an der robotischen Operationstechnik bleibt eine verlängerte warme Ischämiezeit, vor allem während der individuellen Lernkurve. Die hier vorgestellten Umfrageergebnisse zeigen, dass zu diesem aktuellen Thema weiterhin ein großer Diskussionsbedarf besteht, wobei randomisiert-kontrollierte Studien fehlen.